<SEC-DOCUMENT>0001193125-23-032801-index.html : 20230210
<SEC-HEADER>0001193125-23-032801.hdr.sgml : 20230210
<ACCEPTANCE-DATETIME>20230210165752
ACCESSION NUMBER:		0001193125-23-032801
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230210
DATE AS OF CHANGE:		20230210
GROUP MEMBERS:		ADJUVANT CAPITAL GP, L.P.
GROUP MEMBERS:		ADJUVANT CAPITAL MANAGEMENT, L.L.C.
GROUP MEMBERS:		ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND DE, L.P.

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AN2 Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001880438
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				820606654
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-93617
		FILM NUMBER:		23613093

	BUSINESS ADDRESS:	
		STREET 1:		1800 EL CAMINO REAL, SUITE D
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94027
		BUSINESS PHONE:		(650) 331-9090

	MAIL ADDRESS:	
		STREET 1:		1800 EL CAMINO REAL, SUITE D
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94027

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adjuvant Global Health Technology Fund, L.P.
		CENTRAL INDEX KEY:			0001783165
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		C/O ADJUVANT CAPITAL, L.P.
		STREET 2:		501 FIFTH AVENUE, SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		917-334-0724

	MAIL ADDRESS:	
		STREET 1:		C/O ADJUVANT CAPITAL, L.P.
		STREET 2:		501 FIFTH AVENUE, SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>d440609dsc13g.htm
<DESCRIPTION>SC 13G
<TEXT>
Document 1 - file: d440609dsc13g.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d440609dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: d440609dex991.htm

</DOCUMENT>
</SEC-DOCUMENT>